Invention Grant
- Patent Title: Compositions and methods for treating lung inflammation
-
Application No.: US16499979Application Date: 2018-04-19
-
Publication No.: US11767520B2Publication Date: 2023-09-26
- Inventor: John D. Mendlein , Kathleen Ogilvie
- Applicant: aTyr Pharma, Inc.
- Applicant Address: US CA San Diego
- Assignee: aTyr Pharma, Inc.
- Current Assignee: aTyr Pharma, Inc.
- Current Assignee Address: US CA San Diego
- Agency: COOLEY LLP
- International Application: PCT/US2018/028417 2018.04.19
- International Announcement: WO2018/195338A 2018.10.25
- Date entered country: 2019-10-01
- Main IPC: A61K39/385
- IPC: A61K39/385 ; C07K16/46 ; C07K19/00 ; C12N9/00 ; A61P11/00 ; A61P29/00 ; A61K9/48 ; A61K9/51 ; A61K31/4418 ; A61K31/496 ; A61K38/53 ; A61M5/178
Abstract:
Provided are therapies, including combination therapies, for the treatment of lung inflammation, including interstitial lung diseases (ILDs), which include the use of at least one histidyl-tRNA synthetase (HRS) polypeptide or an expressible polynucleotide that encodes the HRS polypeptide, alone or in combination with at least one immunomodulatory agent.
Public/Granted literature
- US20200377874A1 COMPOSITIONS AND METHODS FOR TREATING LUNG INFLAMMATION Public/Granted day:2020-12-03
Information query
